๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evaluation of human lymphoblastoid interferon in advanced malignant melanoma

โœ Scribed by S. Retsas; T. J. Priestman; K. A. Newton; G. Westbury

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
392 KB
Volume
51
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Evaluation of transsphenoidal hypophysec
Evaluation of transsphenoidal hypophysectomy in the management of patients with advanced malignant melanoma
โœ David H. Lawson; Daniel W. Nixon; Marcus L. Black; George T. Tindall; David A. B ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 480 KB ๐Ÿ‘ 2 views

Transsphenoidal hypophysectomy was performed in 13 patients with advanced malignant melanoma. Although three minor responses were observed, there were no complete or partial responses. All three patients with bone pain had a decrease in discomfort lasting 1-2 months. All five patients with minor res

Interferon in combination with vinblasti
Interferon in combination with vinblastine in advanced malignant melanoma. A phase Iโ€“II study
โœ Stein Gundersen; A. Flokkmann ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 1 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol

Heterogeneity in expression of human leu
Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma
โœ Galen A. Ohnmacht; Francesco M. Marincola ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 218 KB ๐Ÿ‘ 1 views

The study of tumor immunology has led to many innovative therapeutic strategies for the treatment of melanoma. The strategies are primarily dependent on melanoma-associated antigen peptide vaccination or T-cell-based therapy. These immunotherapies are totally reliant on proper copresentation of huma